rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2008-10-1
|
pubmed:abstractText |
Oxcarbazepine (Trileptal) is an antiepileptic drug used as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and children. The primary objective of this study was to assess the bioequivalence of Trileptal oral suspension formulation vs. the film-coated tablet after single and multiple twice-daily administrations in fasted, healthy Chinese male subjects.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0946-1965
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
538-44
|
pubmed:meshHeading |
pubmed-meshheading:18826868-Adolescent,
pubmed-meshheading:18826868-Adult,
pubmed-meshheading:18826868-Anticonvulsants,
pubmed-meshheading:18826868-Area Under Curve,
pubmed-meshheading:18826868-Asian Continental Ancestry Group,
pubmed-meshheading:18826868-Carbamazepine,
pubmed-meshheading:18826868-Chromatography, High Pressure Liquid,
pubmed-meshheading:18826868-Cross-Over Studies,
pubmed-meshheading:18826868-Humans,
pubmed-meshheading:18826868-Male,
pubmed-meshheading:18826868-Middle Aged,
pubmed-meshheading:18826868-Suspensions,
pubmed-meshheading:18826868-Tablets, Enteric-Coated,
pubmed-meshheading:18826868-Tandem Mass Spectrometry,
pubmed-meshheading:18826868-Therapeutic Equivalency,
pubmed-meshheading:18826868-Young Adult
|
pubmed:year |
2008
|
pubmed:articleTitle |
Bioequivalence of oxcarbazepine oral suspension vs. film-coated tablet in healthy Chinese male subjects.
|
pubmed:affiliation |
Novartis Pharma AG, Basel, Switzerland. claire.souppart@novartis.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|